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Abstract
Background To investigate the association between
abdominal fat distribution represented by the visceral fat
area (VFA) to subcutaneous fat area (SFA) ratio, and
erosive esophagitis (EE).
Methods Seven hundred and twenty-eight participants aged
[40 years underwent physical examination, blood tests,
esophagogastroduodenoscopy, and abdominal computer
tomography at Chung-Ang University Hospital from 2007
to 2012.
Results Of 728 subjects, 65 (8.9%) had EE. The EE patients
had higher body mass index, metabolic syndrome prevalence,
triglyceride levels, and blood pressure (P\0.05). The mean
VFA/SFA ratio was higher in the EE group than in the non-
EE group (1.30 vs. 0.92, P\0.001). The predominance of
EE in the group with higher VFA/SFA ratio was higher than
in the group with lower VFA/SFA ratio (P\0.001). A VFA/
SFA ratio C1.165 had good accuracy to predict EE (area
under the receiver-operating characteristic curve, 0.643). The
VFA/SFA ratio and visceral fat volume were positively cor-
related with the severity of EE (P = 0.002), and a VFA/SFA
ratio C1.165 was strongly correlated with the severity of EE
(P\0.001).
Conclusion The high VFA/SFA ratio can be a useful
clinical predictor of EE.
Keywords Gastroesophageal reflux disease  Erosive
esophagitis  Visceral fat area  Subcutaneous fat area
Introduction
Gastroesophageal reflux disease (GERD) is a common
disorder. The approximate prevalence of GERD in the
Western world is 10–20% [1]. Mucosal damage produced
by the abnormal reflux of gastric contents into the esoph-
agus is observed in some cases of GERD [2]. Male gender,
hiatal hernia, Helicobacter pylori infection, smoking, and
alcohol consumption can increase the risk of erosive
esophagitis (EE) [3, 4]. In addition, common features of
metabolic syndrome are risk factors for EE [5, 6].
Obesity, a central component of metabolic syndrome, is
known to promote gastroesophageal reflux. Of note, the
increase in intra-abdominal pressure due to obesity con-
tributes to EE. Some studies have suggested that the risk of
GERD or EE increases with increasing body mass index
(BMI) [7–9]. Most studies have used BMI as an indicator
of obesity. However, BMI is an imperfect estimate of
adiposity, particularly in men, owing to the greater muscle
mass in this group [10]. Moreover, the association between
increased BMI and EE is inconsistent and varies with sex,
ethnic origin, and other confounding factors [11–13].
Therefore, the pattern of obesity may be a better pre-
dictor of GERD than BMI [14]. Several studies have sug-
gested that abdominal obesity can be a risk factor for
GERD [15]. A previous study indicated that GERD
symptoms were positively associated with the abdominal
diameter in Caucasian men independently of BMI [16].
Moreover, abdominal adipose tissue consists of subcuta-
neous fat (SF) and visceral fat (VF), and recent studies
revealed the association between abdominal VF and EE
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[17, 18]. A recent study reported that abdominal VF vol-
ume measured by cross-sectional computerized tomogra-
phy (CT) is a more important risk factor for EE than other
factors such as BMI and abdominal circumference in both
sexes [17]. However, because of individual differences in
the absolute amount of VF, this parameter may not indicate
obesity directly; therefore, the relative ratio of VF to SF
may indicate obesity more accurately.
We hypothesized that the ratio of visceral fat area
(VFA) to subcutaneous fat area (SFA), measured by CT,
rather than BMI, might significantly correlate with the risk
of EE. Therefore, the aim of this study was to investigate
the association between abdominal fat distribution, repre-




Subjects older than 40 years were enrolled in a routine
checkup program at the Health Care Center of Chung-Ang
University Hospital from January 2007 to December 2012.
A total of 728 participants underwent a physical exami-
nation (height, body weight, waist circumference, and
blood pressure), blood tests [glucose, triglycerides (TG),
and high-density lipoprotein (HDL) cholesterol], esopha-
gogastroduodenoscopy (EGD), and abdominal CT scan.
The Institutional Review Board approved the study [Pro-
tocol No. C2013001(961)], and all the participants pro-
vided a written informed consent.
Measurement of Anthropometric Parameters
Height and body weight measurements were automated
(GL-150; G-Tech international Co., Uijungbu City, Korea,
Inbody 720; Biospace Co., Chun-An City, Korea), and
BMI was calculated as weight divided by height squared
(kg/m2) [19]. Waist circumference was measured by
trained nurses at the midpoint between the lower borders of
the rib cage and upper pole of the iliac crest. After fasting
for 12 h, blood samples were taken for measurement of
blood lipids and glucose.
Metabolic syndrome was defined on the basis of the
criteria established by the National Cholesterol Education
Program (NCEP). The NCEP criteria for metabolic syn-
drome require that at least three of the following conditions
be met: waist circumference[40 in. in men and[35 in. in
women, plasma TG [150 mg/dl, HDL cholesterol
\40 mg/dl in men and\50 mg/dl in women, blood pres-
sure C130/85 mmHg, and fasting plasma glucose
C110 mg/dl [20].
Endoscopy
EGD was performed using a flexible endoscope (CV-260SL;
Olympus, Tokyo, Japan) after overnight fasting. We inspected
the gastroesophageal junction at the start of the endoscopic
examination before inflation of the stomach or at the end of
the examination after deflation of the stomach. The severity of
EE was graded from A to D according to the Los Angeles
(LA) classification system [21]. Hiatal hernia was considered
present if the gastroesophageal junction extended at least
2 cm above the diaphragmatic hiatus impression during quiet
respiration [22].
Measurement of Abdominal Adipose Tissue Area
by CT
The abdominal adipose tissue area was quantified using
64-multidetector CT (Brilliance; Philips medical systems,
Cleveland, OH, USA). The fat area was determined by
measuring the mean value of the pixels within the range
between -175 and -25 Hounsfield units. The total abdom-
inal fat area (TFA), VFA, and SFA were measured by the
acquisition of a 10-cm CT slice scan image of the third and
fourth lumbar vertebrae during suspended respiration.
The area (cm2) was calculated using Extended Brilliance
Workspace software (version 1-4.5.2, Philips Healthcare,
Best, Netherland). VFA was calculated by delineating the
intra-abdominal cavity bound by the parietal peritoneum or
transversalis fascia, and excluding the vertebral column
and paraspinal muscles. SFA was calculated by subtracting
VFA from TFA.
Statistical Analysis
Categorical variables were evaluated using v2 test or
Fisher’s exact test. Continuous variables were evaluated
using Student’s t test. Continuous variables were expressed
as mean ± SD. A p value of\0.05 was considered sta-
tistically significant. The software package SPSS version
20.0 was used for analysis (SPSS Inc., Chicago, IL, USA).
Results
Baseline Demographic and Clinical Characteristics
of the Subjects
A total of 728 subjects were included in this study. The
mean age of the patients was 47.15 years; 629 (86.4%)
patients were male, and 99 (13.6%) were female. The mean
BMI was 24.66 kg/m2, and 65 (8.9%) patients had meta-
bolic syndrome. On EGD, 65 (8.9%) patients had EE, and
11 (1.5%) patients had hiatal hernias. On CT, the mean
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VFA, SFA, and VFA/SFA ratio were 2886.97, 3627.27,
and 1.02 cm2, respectively (Table 1).
Clinical Characteristics of Subjects With
and Without EE
Among the 728 subjects, 65 (8.9%) patients had EE. The
patients with EE were predominantly female (Table 2).
The mean BMI was higher in the EE group than in the non-
EE group (25.80 vs. 24.40, P = 0.002). Metabolic syn-
drome was more prevalent in the EE group than in the non-
EE group (30.8 vs. 13.7%, P\ 0.001). Moreover, TG and
blood pressure levels were higher in patients with EE. On
EGD, hiatal hernia was more prevalent in the EE group
than in the non-EE group (9.2 vs. 0.8%, P\ 0.001).
However, VFA was not significantly different between the
two groups (1595.00 vs. 1426.00 cm2, P = 0.927). Con-
versely, SFA was higher in the non-EE group than in the
EE group (1226.92 vs. 1514.46 cm2, P = 0.010). More-
over, the mean VFS/SFA ratio was higher in the EE group
than in the non-EE group (1.30 vs. 0.92, P\ 0.001).
Risk Factors for EE
The results of the multivariate logistic regression analysis
demonstrated that hiatal hernia (P\ 0.001), VFA/SFA
ratio C1.165 (P = 0.010), and high TG level (P = 0.015)
were independent risk factors for EE. Hiatal hernia was
Table 1 Baseline demographic and clinical characteristics
Variables
Number of subjects 728








Blood pressure (mean ± SD, mmHg) 124.30 ± 14.72
HDL cholesterol (mg/dl) 49.09 ± 9.21
Triglyceride (mg/dl) 41.78 ± 36.08







VF area (cm2) 2886.97 ± 5260.61
SF area (cm2) 3627.27 ± 7764.85
VF/SF ratio (mean ± SD) 1.02 ± 0.49
BMI body mass index; high blood pressure, C130/85 mmHg or doc-
umented use of antihypertensive therapy, LDL low-density lipoprotein,
HDL high-density lipoprotein, SF subcutaneous fat, VF visceral fat
Table 2 Comparison of clinical characteristics between subjects with reflux esophagitis and those without
Subjects with reflux esophagitis (n = 65) Subjects without reflux esophagitis (n = 663) P value
Age (range, years) 46 (42–50) 48 (42–53) 0.260
Sex 0.003
Male (%) 1 (1.5) 98 (14.8)
Female (%) 64 (98.5) 565 (85.2)
BMI (kg/m2) 25.80 (23.55–27.65) 24.40 (22.70–26.20) 0.002
Metabolic syndrome \0.001
Yes (%) 20 (30.8) 91 (13.7)
No (%) 45 (69.2) 572 (86.3)
HDL cholesterol (mg/dl) 46 (40–52) 48 (43–54) 0.066
Triglyceride (mg/dl) 45 (26–65) 29 (20–49) \0.001
High blood pressure 0.006
Yes (%) 35 (53.8) 242 (36.6)
No (%) 30 (46.2) 420 (63.4)
Fasting glucose (mg/dl) 98.00 (93.50–107.00) 97.00 (91.00–105.00) 0.307
Hiatal hernia 6 (9.2) 5 (0.8) \0.001
VF area (cm2) 1595.00 (841.50–1936.50) 1426.00 (998.00–1950.00) 0.927
SF area (cm2) 1226.92 (707.58–2054.67) 1514.46 (945.68–2772.09) 0.010
VF/SF 1.30 (0.87–1.63) 0.92 (0.67–1.29) \0.001
BMI body mass index; high blood pressure, C130/85 mmHg or documented use of antihypertensive therapy, LDL low-density lipoprotein, HDL
high-density lipoprotein, NS nonspecific, SF subcutaneous fat, VF visceral fat
Dig Dis Sci
123
strongly associated with an increased risk of EE [adjusted
odds ratio (OR), 12.90; 95% confidence interval (CI),
3.57–46.65]. Similarly, a VFA/SFA ratio C1.165 was a
significant risk factor for EE (OR 2.04; 95% CI 1.18–3.51;
Table 3).
Association Between EE and VFA/SFA Ratio
The analysis of the correlation between EE and the VFA/
SFA ratio indicated that the incidence of EE was higher in
the group with the higher VFA/SFA ratio (P\ 0.001;
Fig. 1). In addition, the receiver-operating characteristic
(ROC) curve indicated that a VFA/SFA ratio C1.165 had
good accuracy to predict EE (area under the ROC
curve = 0.643; Fig. 2).
Effect of VFA/SFA Ratio on the Severity of EE
The severity of EE was positively correlated with the VFA/
SFA ratio and VF volume (P = 0.002; Table 4). The risk
of EE types LA-A, LA-B, and LA-C/LAC-D increased
1.23-fold, 1.27-fold, and 1.56-fold, respectively. Of note, a
VFA/SFA ratio C1.165 was strongly correlated with the
severity of EE (P\ 0.001; Table 5).
Discussion
Our study identified a positive correlation between EE and
each of the following individual factors: high BMI, meta-
bolic syndrome, high VFA/SFA ratio, hiatal hernia, high
Table 3 Logistic regression analysis of covariables for erosive esophagitis
Variable OR (95% CI) Univariate analysis (p) OR (95% CI) Multivariate analysis (p)
Age (years)
\65 (n = 714) 1
C65 (n = 14) 1.88 (0.41–8.68) 0.326
Sex
Female (n = 99) 1
Male (n = 629) 0.09 (0.01–0.66) 0.003 0.19 (0.03–1.40) 0.191
BMI (kg/m2)
\25 (n = 665) 1
C25 (n = 63) 2.25 (1.33–3.81) 0.002 1.64 (0.93–2.87) 0.086
Metabolic syndrome
No (n = 663) 1
Yes (n = 65) 2.79 (1.58–4.95) \0.001 0.82 (0.33–2.01) 0.819
HDL cholesterol (mg/dl)
\40 (n = 631) 1
C40 (n = 97) 1.37 (0.69–2.72) 0.371
Triglyceride (mg/dl)
\150 (n = 714) 1
C150 (n = 14) 6.06 (1.97–18.65) 0.005 4.74 (1.35–16.62) 0.015
High blood pressure
No (n = 452) 1
Yes (n = 276) 2.04 (1.22–3.41) 0.006 1.72 (0.97–3.07) 0.065
Fasting glucose (mg/dl)
\110 (n = 609) 1
C110 (n = 119) 0.93 (0.46–1.87) 0.826
Hiatal hernia
No (n = 717) 1
Yes (n = 11) 13.38 (3.97–45.17) 0.001 12.90 (3.57–46.65) \0.001
VF/SF ratio
\1.165 (n = 477) 1
C1.165 (n = 251) 2.77 (1.65–4.65) \0.001 2.04 (1.18–3.51) 0.010
BMI body mass index, CI confidence interval; high blood pressure, C130/85 mmHg or documented use of antihypertensive therapy, LDL low-
density lipoprotein, HDL high-density lipoprotein, VF visceral fat, SF subcutaneous fat
Dig Dis Sci
123
TG level, high blood pressure, and female sex. However,
multivariate analysis revealed that only high VFA/SFA
ratio, hiatal hernia, and high TG level were associated with
EE.
In a previous study, multivariate logistic regression
analysis revealed that VFA was associated with EE [18].
Previous studies demonstrated that women have lower VF
and higher SF than men [17, 23]. In our study, however,
VFA did not show a significant association with EE, as a
higher proportion of women might have resulted in a lower
VFA than expected in the EE group.
In other studies, multivariate analysis found that high
BMI, waist circumference, and waist-to-hip ratio were
associated with EE [17, 18]. Although these parameters are
easily obtainable, these are imperfect measures of adiposity
owing to confounding factors such as sex and ethnic origin.
While in some Asian populations the prevalence of obesity
is lower than that in western countries, health risks asso-
ciated with obesity occur at a lower BMI in Asian popu-
lations, and these populations are predisposed to abdominal
obesity [24].
Several hypotheses have been formulated to explain
how obesity can cause GERD [25–27]. Previous studies
have indicated that obesity can lead to EE via dietary,
mechanical, and humoral factors [15, 26]. A previous study
has shown that the amount and type of dietary intake are
responsible for GERD [28]. Moreover, an increase in
abdominal adipose tissue leads to increased intra-abdomi-
nal and intragastric pressure, increased rate of transit, lower
esophageal sphincter relaxation, formation of hiatal hernia,
and subsequent esophageal acid reflux [25]. Humoral and
hormonal factors are also involved in the correlation
between obesity and GERD. A large cohort study found
that compared to men with obesity, women with obesity
had a greater risk of GERD symptoms, with the risk being
highest in premenopausal women and postmenopausal
women undergoing estrogen therapy [29]. Furthermore, VF
is strongly associated with elevated serum levels of several
proinflammatory cytokines, including interleukin-6 and
Fig. 1 Association between erosive esophagitis and VF/SF ratio. The
incidence of erosive esophagitis was higher in the group with the
higher VFA/SFA ratio (P for trend\0.001)
Fig. 2 AUROC of VF/SF ratio in the identification of erosive
esophagitis. Receiver-operating characteristic (ROC) curve indicated
that a VFA/SFA ratio C1.165 had a good accuracy to predict erosive
esophagitis (AUROC = 0.643). AUROC area under the receiver
operator characteristic curve
Table 4 Association between
visceral fat/subcutaneous fat
ratio and severity of erosive
esophagitis
Normal LA-A LA-B LA-C, D
No. of subjects (%) 663 (91.1) 50 (6.9) 14 (1.9) 1 (0.1)
VF/SF (mean ± SD) 1.00 ± 0.49 1.23 ± 0.53 1.27 ± 0.47 1.56
P value 0.002
VF visceral fat, SF subcutaneous fat
Table 5 Severity of erosive esophagitis according to visceral
fat/subcutaneous fat ratio
Normal LA-A LA-B LA-C, D
No. of subjects (%) 663 (91.1) 50 (6.9) 14 (1.9) 1 (0.1)
VF/SF\1.165 449 (94.1) 24 (5.0) 4 (0.9) 0 (0.0)
VF/SF C1.165 214 (85.3) 26 (10.3) 10 (4.0) 1 (0.4)
P for trend \0.001
P value \0.001
VF visceral fat, SF subcutaneous fat
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tumor necrosis factor-alpha, which are overexpressed in
patients with EE [30, 31].
Several studies have evaluated obesity by measuring
BMI and waist circumference. BMI is associated with
increased transient lower esophageal sphincter relaxation
[32]. Waist circumference and BMI are significantly cor-
related with intragastric pressure, gastroesophageal pres-
sure gradient, and separation of the gastroesophageal
junction pressure components [33, 34]. However, the
association between BMI and GERD is affected by many
confounding factors [7, 12, 13, 16]. Moreover, anthropo-
metric measurements are less accurate and less repro-
ducible in obesity studies.
Abdominal visceral adipose tissue, which is associated
with increased intra-abdominal pressure, may be a better
predictor of GERD than other obesity parameters. The
most important mechanism involved in the correlation
between obesity with GERD is intra-abdominal pressure,
which plays a significant role in acid reflux [35]. Moreover,
abdominal CT is more accurate and more reproducible than
anthropometry because CT allows for the direct assessment
of SF and VF compartments, whereas anthropometric
measurements do not. VFA is an indicator of abdominal fat
and a strong predictor of insulin resistance and coronary
artery disease [33, 36]. However, the high cost and radia-
tion exposure should be considered.
In our study, the VFA/SFA ratio was a more significant
risk factor for EE than BMI, waist circumference, waist-to-
hip ratio, and VFA. Moreover, we found that a VFA/SFA
ratio C1.165 might be a useful indicator for predicting EE.
In addition, the severity of EE was positively correlated
with the VFA/SFA ratio.
Our study has several strengths. First, the methods used
allowed for the acquisition of high-quality data. Further-
more, EE was objectively evaluated via EGD and catego-
rized using the Los Angeles classification, and minor
changes were excluded to increase specificity. Second,
abdominal adipose tissue was measured using 64-multi-
detector CT, which has a high degree of validity and
reproducibility [23]. Furthermore, we suggested cutoff
values for normal versus abnormal VFA/SFA ratios.
Our study also has the following limitations. First, the
study population was based on subjective screening;
therefore, there could have been a selection bias. Second,
we did not evaluate individual diet or lifestyle factors such
as alcohol consumption and smoking status.
Conclusion
The VFA/SFA ratio was positively associated with EE. The
pattern of obesity was more important than BMI, and the
VFA/SFA ratio was used in the diagnosis of VF-type
abdominal obesity. We suggest that a high VFA/SFA ratio
is a useful clinical predictor of EE. Therefore, individuals
with a high VFA/SFA ratio may need endoscopic evalua-
tion for EE. Further studies are needed to determine the
treatment success of EE based on the VFA/SFA ratios.
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